Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Tumor ablation · Minnesota | Tumor ablation · Illinois | |
|---|---|---|
| Surgeons, 2024 | 7 | 2 |
| Medicare fee-for-service cases | 358 | 357 |
| Growth since 2019 (Medicare FFS) | +1.3%/yr | +0.9%/yr |
| Forecast cases (Medicare FFS) | 500 in 2030 | 740 in 2030 |
| Forecast growth | +5.8%/yr to 2030 | +13%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.8 | 0.3 |
| Medicare Advantage share | 64% | 47% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 51 | 179 |
| Top 10 surgeons' share | 100% | 100% |
| Surgeons growing | 2 | 0 |
| New since the base year | 2 | 1 |
| Likely to stop billing it | 1 by 2026 | 1 by 2026 |
| Forecast miss, 1 year (procedure) | 15% | 15% |
| Company payments per surgeon | $75K | $502K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.